Short Interest in Starpharma Holdings Limited (OTCMKTS:SPHRY) Declines By 42.2%

Starpharma Holdings Limited (OTCMKTS:SPHRY) saw a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 2,600 shares, a decline of 42.2% from the October 31st total of 4,500 shares. Based on an average daily volume of 12,000 shares, the days-to-cover ratio is presently 0.2 days.

Starpharma Stock Performance

OTCMKTS SPHRY remained flat at $0.67 during trading hours on Thursday. The company had a trading volume of 50 shares, compared to its average volume of 4,947. Starpharma has a fifty-two week low of $0.52 and a fifty-two week high of $1.33. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.94 and a quick ratio of 4.58. The firm has a fifty day moving average of $0.68 and a 200-day moving average of $0.65.

About Starpharma

Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.